Craig A Collard - Net Worth and Insider Trading

Craig A Collard Net Worth

The estimated net worth of Craig A Collard is at least $2 Million dollars as of 2024-04-19. Craig A Collard is the Director of Opiant Pharmaceuticals Inc and owns about 53,822 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $1 Million. Craig A Collard is also the Director of Sierra Oncology Inc and owns about 13,500 shares of Sierra Oncology Inc (SRRA) stock worth over $742,365. Details can be seen in Craig A Collard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Craig A Collard has not made any transactions after 2022-06-13 and currently still holds the listed stock(s).

Transaction Summary of Craig A Collard

To

Craig A Collard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Craig A Collard owns 3 companies in total, including Opiant Pharmaceuticals Inc () , Sierra Oncology Inc () , and Heron Therapeutics Inc () .

Click here to see the complete history of Craig A Collard’s form 4 insider trades.

Insider Ownership Summary of Craig A Collard

Ticker Comapny Transaction Date Type of Owner
Opiant Pharmaceuticals Inc 2022-06-13 director
Sierra Oncology Inc 2021-11-24 director
Heron Therapeutics Inc 2023-02-22 director

Craig A Collard Latest Holdings Summary

Craig A Collard currently owns a total of 2 stocks. Among these stocks, Craig A Collard owns 53,822 shares of Opiant Pharmaceuticals Inc (OPNT) as of June 13, 2022, with a value of $1 Million and a weighting of 59.95%. Craig A Collard also owns 13,500 shares of Sierra Oncology Inc (SRRA) as of November 24, 2021, with a value of $742,365 and a weighting of 40.05%.

Latest Holdings of Craig A Collard

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPNT Opiant Pharmaceuticals Inc 2022-06-13 53,822 20.65 1,111,424
SRRA Sierra Oncology Inc 2021-11-24 13,500 54.99 742,365

Holding Weightings of Craig A Collard


Craig A Collard Form 4 Trading Tracker

According to the SEC Form 4 filings, Craig A Collard has made a total of 4 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the acquisition of 5,700 shares on June 13, 2022, which cost Craig A Collard around $63,270.

According to the SEC Form 4 filings, Craig A Collard has made a total of 1 transactions in Sierra Oncology Inc (SRRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sierra Oncology Inc is the acquisition of 13,500 shares on November 24, 2021, which cost Craig A Collard around $310,905.

Insider Trading History of Craig A Collard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Craig A Collard Trading Performance

GuruFocus tracks the stock performance after each of Craig A Collard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig A Collard is 42.55%. GuruFocus also compares Craig A Collard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig A Collard within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Craig A Collard's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Craig A Collard

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.68 42.55 56.34 -38.71
Relative Return to S&P 500(%) 19.43 40.02 60.36 -28.32

Craig A Collard Ownership Network

Ownership Network List of Craig A Collard

No Data

Ownership Network Relation of Craig A Collard


Craig A Collard Owned Company Details

What does Opiant Pharmaceuticals Inc do?

Who are the key executives at Opiant Pharmaceuticals Inc?

Craig A Collard is the director of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , Chief Scientific Officer Phil Skolnick , and director & 10 percent owner & Chief Executive Officer Roger Crystal .

Opiant Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Craig A Collard made no insider transaction in Opiant Pharmaceuticals Inc (). Other recent insider transactions involving Opiant Pharmaceuticals Inc () include a net sale of 7,570 shares made by Roger Crystal , a net sale of 2,885 shares made by Ellison Mark Jason Heath , and a net sale of 2,556 shares made by David D O'toole .

In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.

Opiant Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Opiant Pharmaceuticals Inc Insider Transactions

No Available Data

Craig A Collard Mailing Address

Above is the net worth, insider trading, and ownership report for Craig A Collard. You might contact Craig A Collard via mailing address: C/o Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary Nc 27518.

Discussions on Craig A Collard

No discussions yet.